• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Evotec Se (OP: EVOTF )

    6.773 UNCHANGED
    Last Price Updated: 12:15 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 6.773
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 6.773
    Today's Range 6.773 - 6.773
    52wk Range 6.570 - 24.61
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
    Via ACCESSWIRE
    Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
    Reuters 
    Via Benzinga

    Performance

    YTD
    -68.76%
    -68.76%
    1 Month
    N/A
    N/A
    3 Month
    +3.09%
    +3.09%
    6 Month
    N/A
    N/A
    1 Year
    -72.48%
    -72.48%

    More News

    Read More
    Evotec Secures US Government Contract For Orthopoxvirus Antibody
    Via Benzinga
    Adapsyn Bioscience Inks Collaboration Pact With Evotec
    Via Benzinga
    The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
    Via Benzinga
    Evotec Enters a Drug Discovery Collaboration with Janssen
    From Evotec SE
    Via AccessWire
    Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
    From Evotec AG
    Via AccessWire
    Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures
    From Evotec AG
    Via AccessWire
    Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
    From Evotec AG
    Via AccessWire
    Why Are Evotec Shares Trading Lower On Friday?
    Via Benzinga
    Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
    From Evotec AG
    Via AccessWire
    Exposures COVID-19
    Germany Based Evotec Sets Terms For $576M US IPO
    Via Benzinga
    Pasithea, Evotec Ink Drug Development Pact
    Via Benzinga
    Evotec Expands Neuroscience Collaboration with Bristol Myers
    Via Benzinga
    Bristol Myers Exercises Option In-License Evotec's Neurodegenerative Candidate
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.